Therapeutic implications of baricitinib in mouse model of vitiligo
Archives of Dermatological Research · 2025
DOI: 10.1007/s00403-025-03879-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Dermatological Research, 2025. Verfasst von Harjot Kaur und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Zoology, Panjab University, Chandigarh, 160014, India. Hauptthemen laut MEDLINE: Purines, Vitiligo, Azetidines, Sulfonamides. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Vitiligo, an autoimmune disorder marked by skin depigmentation, is closely linked to immune dysregulation, including T cell infiltration and pro-inflammatory cytokines. This study explores the potential of baricitinib, a JAK-STAT inhibitor, in promoting repigmentation in vitiligo lesions by modulating immune responses. METHODS: Using a mouse model of vitiligo induced by hydroquinone, we assessed the effects of baricitinib treatment on lesion repigmentation, CD8 + T cell infiltration, T cell populations, and serum TNF-α levels. Immunostaining, flow cytometry, and ELISA were used to analyse these parameters. RESULTS: Baricitinib treatment significantly reduced CD8 + T cell infiltration in the skin, lowered serum TNF-α levels, and decreased both CD4 + and CD8 + T cell populations in the blood. Remarkably, these immune modulations correlated with notable repigmentation of the lesions. CONCLUSION: Baricitinib effectively reduces inflammation and T cell infiltration, suggesting it as a promising therapeutic for vitiligo. These findings highlight its potential to modulate immune responses and restore skin pigmentation in vitiligo patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Zoology, Panjab University, Chandigarh, 160014, India.
- Department of Dermatology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
- Department of Zoology, Panjab University, Chandigarh, 160014, India. ravinder03@gmail.com.
Zitieren
APA
Kaur, H., Thakur, K., Parsad, D., & Kumar, R. (2025). Therapeutic implications of baricitinib in mouse model of vitiligo. Archives of Dermatological Research. https://doi.org/10.1007/s00403-025-03879-8
Vancouver
Kaur H, Thakur K, Parsad D, Kumar R. Therapeutic implications of baricitinib in mouse model of vitiligo. Archives of Dermatological Research. 2025. doi:10.1007/s00403-025-03879-8
BibTeX
@article{Kaur2025,
author = {Kaur, Harjot and Thakur, Kanika and Parsad, Davinder and Kumar, Ravinder},
title = {Therapeutic implications of baricitinib in mouse model of vitiligo},
journal = {Archives of Dermatological Research},
year = {2025},
doi = {10.1007/s00403-025-03879-8}
}
EUVIMED